Monday June 26th 2017

Archive for January, 2017

U.S. court rejects Teva’s patent-infringement claims on Copaxone

U.S. court rejects Teva’s patent-infringement claims on Copaxone

(Reuters) - Teva Pharmaceutical Industries Ltd said on Monday a U.S. court rejected four of the Israel-based drugmaker's claims of patent infringement on its top-selling multiple sclerosis treatment. (Source: Reuters: Health) [Read More]

HIV infection may make patients vulnerable to diabetes

HIV infection may make patients vulnerable to diabetes

Prevalence is 3.8% higher in HIV-positive adults Related items fromOnMedica HIV antiretroviral drugs may lower multiple sclerosis risk HIV therapy helps protect men from Hep B infection UK HIV diagnosis rates twice as high as western Europe Preventing HIV NHS England loses [Read More]

Aggressive traits in people with multiple sclerosis-a case-control study – Fragoso YD, Going LC, Lourido AM, Berlim LV, Egas MB, Souza MR.

Aggressive traits in people with multiple sclerosis-a case-control study – Fragoso YD, Going LC, Lourido AM, Berlim LV, Egas MB, Souza MR.

OBJECTIVE: Multiple sclerosis (MS) is a chronic neuroimmunological disease that mainly affects young adults and leads to neurological disabilities. Depression, anxiety, cognitive dysfunction, and other psychiatric conditions have often been reported in pat... (Source: [Read More]

 Page 1 of 24  1  2  3  4  5 » ...  Last » 

Latest Topics

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill

MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Best multiple sclerosis blogs

Best multiple sclerosis blogs

Multiple sclerosis blogs are both helpful and inspirational for people affected by the disease. We have selected the 10 [Read More]